Brain Diseases and Disorders

29

[34] S. Guerreiro, A. Privat, L. Bressac, et al., “Cd38 in neurodegeneration

and neuroinflammation,” Cells, vol. 9, 2020.

[35] L. Gan, M. R. Cookson, L. Petrucelli, et al., “Converging pathways in

neurodegeneration, from genetics to mechanisms,” Nature Neuroscience,

vol. 21, pp. 1300–1309, 2018.

[36] L. K. Wareham, S. A. Liddelow, S. Temple, et al., “Solving neurode-

generation: common mechanisms and strategies for new treatments,”

Molecular Neurodegeneration, vol. 17, 2022.

[37] S. Gilman and D. Pushkar, “Subject–volume 11 - number 1-6, january

- december 1996,” American Journal of Alzheimer’s Disease and Other

Dementias, vol. 12, pp. 45–47, 1997.

[38] M. T. Koyun, S. Şirin, S. A. Erdem, et al., “Pyocyanin isolated from

pseudomonas aeruginosa: Characterization, biological activity and its

role in cancer and neurodegenerative diseases,” Brazilian Archives of

Biology and Technology, 2022.

[39] B. J. Kelley and R. C. Petersen, “Alzheimer’s disease and mild cognitive

impairment,” 2009.

[40] M. K. Samanta, B. Wilson, K. Santhi, et al., “Alzheimer disease and

its management: A review,” American Journal of Therapeutics, vol. 13,

pp. 516–526, 2006.

[41] F. Aragón, M. A. Zea-Sevilla, J. Montero, et al., “Oral health in

alzheimer’s disease: a multicenter case-control study,” Clinical Oral In-

vestigations, vol. 22, pp. 3061–3070, 2018.

[42] N. B. Mutlu, Z. Değim, S. Yılmaz, et al., “New perspective for the

treatment of alzheimer diseases: Liposomal rivastigmine formulations,”

Drug Development and Industrial Pharmacy, vol. 37, pp. 775–789, 2011.

[43] M. Racchi, M. Mazzucchelli, E. Porrello, et al., “Acetylcholinesterase

inhibitors: novel activities of old molecules,” Pharmacological research,

vol. 50 4, pp. 441–451, 2004.

[44] P. M. Arabi, V. Deepa, D. Susheel, et al., “Early detection and charac-

terization of alzheimer’s using medical image analysis,” 2018.

[45] S. P. Cass, “Alzheimer’s disease and exercise: A literature review,” Cur-

rent Sports Medicine Reports, vol. 16, p. 19–22, 2017.

[46] H. Öhman, N. Savikko, T. E. Strandberg, et al., “Effects of exercise

on functional performance and fall rate in subjects with mild or ad-

vanced alzheimer’s disease: Secondary analyses of a randomized con-

trolled study,” Dementia and Geriatric Cognitive Disorders, vol. 41,

pp. 233–241, 2016.